Phibro Animal Health Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US71742Q1067
USD
55.48
1.68 (3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Phibro Animal Health Corp.
Soleno Therapeutics, Inc.
Arcutis Biotherapeutics, Inc.
Arbutus Biopharma Corp.
Nurix Therapeutics, Inc.
MacroGenics, Inc.
Coherus BioSciences, Inc.
EyePoint Pharmaceuticals, Inc.
Erasca, Inc.
Oric Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc.

Why is Phibro Animal Health Corp. ?

1
With a growth in Net Profit of 762.14%, the company declared Outstanding results in Dec 25
  • The company has declared positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 93.07 MM
  • NET SALES(HY) At USD 737.8 MM has Grown at 29.51%
  • ROCE(HY) Highest at 31.8%
2
With ROCE of 17.46%, it has a very attractive valuation with a 2.75 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 145.66%, its profits have risen by 574.3% ; the PEG ratio of the company is 0
3
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
  • Along with generating 145.66% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Phibro Animal Health Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Phibro Animal Health Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Phibro Animal Health Corp.
151.5%
4.11
52.95%
S&P 500
16.12%
0.84
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.91%
EBIT Growth (5y)
17.48%
EBIT to Interest (avg)
4.29
Debt to EBITDA (avg)
3.40
Net Debt to Equity (avg)
2.50
Sales to Capital Employed (avg)
1.29
Tax Ratio
37.11%
Dividend Payout Ratio
40.46%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.74%
ROE (avg)
15.62%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
6.25
EV to EBIT
15.73
EV to EBITDA
12.19
EV to Capital Employed
2.75
EV to Sales
1.87
PEG Ratio
0.04
Dividend Yield
0.94%
ROCE (Latest)
17.46%
ROE (Latest)
29.70%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

31What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 93.07 MM

NET SALES(HY)

At USD 737.8 MM has Grown at 29.51%

ROCE(HY)

Highest at 31.8%

NET PROFIT(Q)

Highest at USD 30.1 MM

RAW MATERIAL COST(Y)

Fallen by -11.22% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 7.18 times

OPERATING PROFIT(Q)

Highest at USD 67.31 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18 %

PRE-TAX PROFIT(Q)

Highest at USD 39.93 MM

EPS(Q)

Highest at USD 0.67

-2What is not working for the Company
DIVIDEND PAYOUT RATIO(Y)

Lowest at 17.9%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.12 times

Here's what is working for Phibro Animal Health Corp.

Pre-Tax Profit
At USD 39.93 MM has Grown at 415.34%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 30.1 MM has Grown at 490.12%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Profit
Highest at USD 30.1 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
At USD 737.8 MM has Grown at 29.51%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD 93.07 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD 67.31 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 18 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 39.93 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS
Highest at USD 0.67
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Debtors Turnover Ratio
Highest at 7.18 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -11.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 12.89 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Phibro Animal Health Corp.

Inventory Turnover Ratio
Lowest at 2.12 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Dividend Payout Ratio
Lowest at 17.9%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)